Indinavir: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Indinavir. Educational only — not medical advice.
Labeled uses
CRIXIVAN in combination with antiretroviral agents is indicated for the treatment of HIV infection. This indication is based on two clinical trials of approximately 1 year duration that demonstrated: 1) a reduction in the risk of AIDS-defining illnesses or death; 2) a prolonged suppression of HIV RNA.
Source: FDA labeling via NIH DailyMed (set 702727cb…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.